BTG3 and systemic lupus erythematosus: Following pristane injection, we observed lupus-like symptoms, including splenomegaly, elevated urinary protein levels, increased serum autoantibodies (anti-dsDNA and ANA), and renal injury characterized by glomerular hypertrophy, proliferation of mesangial and endothelial cells, and edema degeneration of renal tubular epithelial cells.